Share the experience with Nexans and the Institut Curie Research Centre

Nexans wanted to carry out a sponsorship campaign for the Institut Curie Research Centre, the foremost French centre for research and fighting cancer, founded in 1909 by Marie Curie.

As a leading player, the Institut Curie Research Centre develops basic and applied scientific research in physics, chemistry, biology, radiobiology and medicine, with a view to putting science at the service of humans to help in the fight against cancer and for the existing or future medical resources needed for this purpose.

The Institut Curie Research Centre combines an internationally renowned research centre with a state-of-the art hospital complex that treats patients with cancers, including the rarest.

Nexans supports the Institut Curie Research Centre through two projects: CHEMICAL BIOLOGY and SIREDO

• CHEMICAL BIOLOGY seeks to supplement and optimise chemotherapy treatments by developing new molecules capable of blocking cellular plasticity. This is key work to continue progress in the fight against the disease. Raphaël Rodriguez, a renowned chemist, and his team recently synthesised a new molecule: Ironomycin. Still at the preclinical study stage, it blocks the effect of iron in breast cancer stem cells.
  At the end of 2021, the Institut Curie Research Centre announced the creation of the first Chemical Biology centre in France. What is the goal of this unique structure? The development of new diagnostic tools and innovative therapeutic approaches in oncology.
• The creation of the SIREDO centre (for Care, Innovation and Research for Children and Adolescents), under the direction of Dr Olivier Delattre, an integral part of the Curie Institute buildings for the construction of a new wing at the Paris hospital. The objective: to bring together all paediatric research teams in direct contact with the paediatric department. The Institut Curie Research Centre is a reference centre for the treatment of childhood cancers and sees more than 700 young patients each year.